News

Published on 1 Apr 2024 on Zacks via Yahoo Finance

Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade


Article preview image

Shares of Annexon, Inc. (ANNX) have gained 20.1% over the past four weeks to close the last trading session at $7.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.42 indicates a potential upside of 101.1%.

The mean estimate comprises six short-term price targets with a standard deviation of $8.04. While the lowest estimate of $8.50 indicates an 18.6% increase from the current price level, the most optimistic analyst expects the stock to surge 318.4% to reach $30. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.

NASDAQ.ANNX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Are Analysts Bullish on Annexon, Inc. (ANNX) Right Now?

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 18 Jun 2024

Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?

Annexon, Inc. ANNX, a clinical-stage company, is focused on developing novel therapies to treat p...

Zacks via Yahoo Finance 1 May 2024

Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)

Annexon, Inc. (ANNX) has been beaten down lately with too much selling pressure. While the stock ...

Zacks via Yahoo Finance 25 Apr 2024

Are Medical Stocks Lagging Annexon (ANNX) This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the gro...

Zacks via Yahoo Finance 18 Apr 2024

Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know

Annexon, Inc. (ANNX) ended the recent trading session at $6.17, demonstrating a -0.96% swing from...

Zacks via Yahoo Finance 10 Apr 2024

Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade

Shares of Annexon, Inc. (ANNX) have gained 20.1% over the past four weeks to close the last tradi...

Zacks via Yahoo Finance 1 Apr 2024

What Makes Annexon (ANNX) a New Buy Stock

Investors might want to bet on Annexon, Inc. (ANNX), as it has been recently upgraded to a Zacks ...

Zacks via Yahoo Finance 1 Apr 2024

Steven Cohen's Point72 Asset Management Acquires New Stake in Annexon Inc

Overview of Steven Cohen (Trades, Portfolio)'s Investment in Annexon Inc Warning! GuruFocus has d...

GuruFocus.com via Yahoo Finance 13 Feb 2024

Recent uptick might appease Annexon, Inc. (NASDAQ:ANNX) institutional owners after losing 18% over...

Key Insights Given the large stake in the stock by institutions, Annexon's stock price might be v...

Simply Wall St. via Yahoo Finance 10 Feb 2024